FDA Drug Application (022097) for STAVUDINE; LAMIVUDINE; EFAVIRENZ by STRIDES ACROLAB

Back to FDA Applications sponsored by STRIDES ACROLAB

Application Number022097
Product Number001
FormTABLET; ORAL
Dosage40MG; 150MG; 600MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSTAVUDINE; LAMIVUDINE; EFAVIRENZ
Active IngredientSTAVUDINE; LAMIVUDINE; EFAVIRENZ

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient STAVUDINE11


Back to FDA Applications sponsored by STRIDES ACROLAB